Present & future of cancer #Immunotherapy: evidence suggests that pts not responding to PD-1/PD-L1-targeted agents do not have PD-L1-expressing tumoursRead more on the ESMO Daily Reporter & don’t miss the #ESMO20 Keynote Lecture by Lieping Chen (17/10) http://ow.ly/UK5550BTbQP
An immuno tease.
- Forums
- ASX - By Stock
- IMM
- LAG525 Solid and Hematologic Malignancies trial completed
LAG525 Solid and Hematologic Malignancies trial completed, page-38
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
31.5¢ |
Change
0.005(1.61%) |
Mkt cap ! $458.1M |
Open | High | Low | Value | Volume |
31.0¢ | 31.5¢ | 30.5¢ | $251.5K | 806.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 121215 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.5¢ | 2864 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 121215 | 0.310 |
21 | 282998 | 0.305 |
21 | 464160 | 0.300 |
6 | 89833 | 0.295 |
11 | 293135 | 0.290 |
Price($) | Vol. | No. |
---|---|---|
0.315 | 2864 | 3 |
0.320 | 175639 | 5 |
0.325 | 392741 | 5 |
0.330 | 168348 | 4 |
0.335 | 196676 | 5 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |